Acclarent: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
Acclarent | == Acclarent == | ||
[[File:Acclarent_Logo.svg|thumb|right|Acclarent logo]] | [[File:Acclarent_Logo.svg|thumb|right|Acclarent logo]] | ||
'''Acclarent''' is a medical technology company that specializes in the development of innovative devices for the treatment of ear, nose, and throat (ENT) conditions. | '''Acclarent''' is a medical technology company that specializes in the development of innovative devices for the treatment of ear, nose, and throat (ENT) conditions. Founded in 2004, Acclarent has been at the forefront of minimally invasive procedures, particularly in the field of sinus surgery. | ||
==History== | === History === | ||
Acclarent was | Acclarent was established with the goal of improving patient care through the development of less invasive surgical options. The company quickly gained recognition for its pioneering work in balloon sinuplasty, a technique that uses a small, flexible balloon catheter to open up blocked sinus passageways. | ||
=== Products === | |||
Acclarent's product line includes a range of devices designed to assist ENT specialists in performing procedures with greater precision and less trauma to the patient. Some of the key products include: | |||
* '''Balloon Sinuplasty Systems''': These systems are used to treat chronic sinusitis by dilating the sinus openings, allowing for better drainage and relief of symptoms. | |||
* '''Relieva Spin Balloon Sinuplasty System''': A specific type of balloon sinuplasty device that offers enhanced navigation and control during procedures. | |||
* '''Cyclone''': A suction and irrigation system designed to clear sinus cavities during surgery. | |||
=== Innovations === | |||
Acclarent has been instrumental in advancing the field of ENT surgery through its commitment to research and development. The company's focus on minimally invasive techniques has led to improved outcomes for patients, including reduced recovery times and less postoperative discomfort. | |||
== | === Acquisition === | ||
Acclarent | In 2010, Acclarent was acquired by [[Johnson & Johnson]], a global leader in healthcare products. This acquisition allowed Acclarent to expand its reach and continue its mission of improving ENT care worldwide. | ||
== Related pages == | |||
* [[Balloon Sinuplasty]] | |||
==Related pages== | |||
* [[Balloon | |||
* [[Sinusitis]] | * [[Sinusitis]] | ||
* [[Johnson & Johnson]] | * [[Johnson & Johnson]] | ||
* [[Ear, Nose, and Throat Surgery]] | |||
[[Category:Medical technology companies]] | [[Category:Medical technology companies]] | ||
[[Category:Healthcare companies | [[Category:Healthcare companies established in 2004]] | ||
[[Category: | [[Category:Johnson & Johnson subsidiaries]] | ||
Latest revision as of 03:36, 13 February 2025
Acclarent[edit]

Acclarent is a medical technology company that specializes in the development of innovative devices for the treatment of ear, nose, and throat (ENT) conditions. Founded in 2004, Acclarent has been at the forefront of minimally invasive procedures, particularly in the field of sinus surgery.
History[edit]
Acclarent was established with the goal of improving patient care through the development of less invasive surgical options. The company quickly gained recognition for its pioneering work in balloon sinuplasty, a technique that uses a small, flexible balloon catheter to open up blocked sinus passageways.
Products[edit]
Acclarent's product line includes a range of devices designed to assist ENT specialists in performing procedures with greater precision and less trauma to the patient. Some of the key products include:
- Balloon Sinuplasty Systems: These systems are used to treat chronic sinusitis by dilating the sinus openings, allowing for better drainage and relief of symptoms.
- Relieva Spin Balloon Sinuplasty System: A specific type of balloon sinuplasty device that offers enhanced navigation and control during procedures.
- Cyclone: A suction and irrigation system designed to clear sinus cavities during surgery.
Innovations[edit]
Acclarent has been instrumental in advancing the field of ENT surgery through its commitment to research and development. The company's focus on minimally invasive techniques has led to improved outcomes for patients, including reduced recovery times and less postoperative discomfort.
Acquisition[edit]
In 2010, Acclarent was acquired by Johnson & Johnson, a global leader in healthcare products. This acquisition allowed Acclarent to expand its reach and continue its mission of improving ENT care worldwide.